Want to see AU:NUC full AI Analyst Report?
NUC Stock Chart & Stats
AU$0.12
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.12
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.07 - AU$0.23
Previous CloseN/A
Volume11.15K
Average Volume (3M)7.76K
Market Cap
AU$13.33M
Enterprise ValueAU$16.50
Total Cash (Recent Filing)AU$3.11M
Total Debt (Recent Filing)AU$529.14K
Price to Earnings (P/E)―
Beta0.74
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding156,818,770
10 Day Avg. Volume3,027
30 Day Avg. Volume7,761
Financial Highlights & Ratios
PEG Ratio0.09
Price to Book (P/B)1.82
Price to Sales (P/S)0.89
P/FCF Ratio-5.19
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)AU$28.30M
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthSustained ~45% top-line growth signals robust demand and successful go-to-market execution in core categories. Over 2–6 months this provides scale levers (higher absolute gross profit, stronger retailer leverage) and a clearer runway for margin recovery if cost control follows.
Conservative LeverageLow debt levels reduce default risk and give management flexibility to fund operations or invest in marketing and distribution without immediate refinancing pressure. This structural balance-sheet strength supports resilience amid cash-flow variability.
Niche Brand & Multi-Channel ModelA focused infant/children probiotics brand with both wholesale and direct-to-consumer channels provides diversified revenue pathways and repeat-purchase potential. The niche health positioning and multi-channel distribution are durable advantages for customer retention and geographic expansion.
Bears Say
Negative Cash FlowsPersistent negative operating and free cash flows indicate the business is not self-funding growth. Over months this raises the probability of external financing, constraint on marketing or R&D spend, and pressure on liquidity, reducing strategic optionality.
Ongoing Losses / Negative ROENegative ROE and ongoing net losses show the company is not converting invested capital into shareholder returns. Structurally, this undermines investor confidence and makes capital raising more dilutive or costly, limiting long-term growth investments.
Profitability Not Keeping PaceRevenue growth without margin improvement implies unfavorable unit economics or high operating costs. Over several months this erodes free cash flow potential, hampers scalability, and suggests underlying issues in pricing, COGS, or channel economics that must be fixed to reach sustainable profitability.
Nuchev Pty Ltd News
NUC FAQ
What was Nuchev Pty Ltd’s price range in the past 12 months?
Nuchev Pty Ltd lowest share price was AU$0.07 and its highest was AU$0.23 in the past 12 months.
What is Nuchev Pty Ltd’s market cap?
Nuchev Pty Ltd’s market cap is AU$13.33M.
When is Nuchev Pty Ltd’s upcoming earnings report date?
Nuchev Pty Ltd’s upcoming earnings report date is Aug 27, 2026 which is in 42 days.
How were Nuchev Pty Ltd’s earnings last quarter?
Nuchev Pty Ltd released its earnings results on Feb 24, 2026. The company reported -AU$0.02 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Nuchev Pty Ltd overvalued?
According to Wall Street analysts Nuchev Pty Ltd’s price is currently Overvalued.
Does Nuchev Pty Ltd pay dividends?
Nuchev Pty Ltd does not currently pay dividends.
What is Nuchev Pty Ltd’s EPS estimate?
Nuchev Pty Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nuchev Pty Ltd have?
Nuchev Pty Ltd has 156,818,770 shares outstanding.
What happened to Nuchev Pty Ltd’s price movement after its last earnings report?
Nuchev Pty Ltd reported an EPS of -AU$0.02 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Nuchev Pty Ltd?
Currently, no hedge funds are holding shares in AU:NUC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Nuchev Pty Ltd Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-10.34%
12-Months-Change
Fundamentals
Return on Equity
-41.69%
Trailing 12-Months
Asset Growth
-1.10%
Trailing 12-Months
Company Description
Nuchev Pty Ltd
Nuchev Limited functions as a specialized health and nutrition company, responsible for the production, marketing, and distribution of infant formula and various nutritional items derived from goat milk. Its products are sold to consumers across Australia, China, and Vietnam. The firm offers a range of options under its Oli6 brand, including toddler nutrition, powdered goat milk, and general health and wellness goods. These products can be purchased through both conventional retail outlets and online e-commerce platforms. Nuchev Limited was established in 2013 and maintains its corporate headquarters in Melbourne, Australia.
Technical Analysis
Noumi Limited
―
Australian Dairy Nutritionals Group
―
Bubs Australia Ltd.
―
Nutritional Growth Solutions Ltd.
―
Clover Corporation Limited
―